Related Experiment Video

Updated: Nov 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

[CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]

Grégoire Wuerzner1, Bernard Waeber2

  • 1Service de Néphrologie et Hypertension, CHUV, Lausanne.

Praxis
|February 3, 2021
PubMed

Insights

Hypertensive patients face no increased risk of severe COVID-19 complications. Current treatments, including renin-angiotensin system blockers, and COVID-19 vaccines are safe for managing high blood pressure during the pandemic.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic poses significant public health challenges.
  • Certain populations, including older adults and those with diabetes, obesity, or hypertension, are at higher risk for severe complications.

Purpose of the Study:

  • To evaluate the specific risks and management considerations for hypertensive patients during the COVID-19 pandemic.
  • To determine if existing hypertension treatments and COVID-19 vaccines are safe for this patient group.

Main Methods:

  • Review of current observational data and clinical findings related to hypertension and COVID-19.
  • Analysis of the safety of renin-angiotensin system blockers in hypertensive patients with COVID-19.
  • Assessment of the safety of COVID-19 vaccination in hypertensive individuals.

Main Results:

  • Current data suggest that hypertensive patients, whether treated or not, do not face a confirmed increased risk of severe COVID-19 outcomes.
  • Treatments involving blockers of the renin-angiotensin system appear safe for hypertensive patients.
  • COVID-19 vaccines can be safely administered to patients with high blood pressure.

Conclusions:

  • There is currently no evidence to necessitate changes in the standard care of hypertensive patients due to the COVID-19 pandemic.
  • Hypertensive patients can continue their prescribed treatments and receive COVID-19 vaccinations without undue concern.

Keywords:
Blocker des Renin-Angiotensin-SystemsBluthochdruckCOVID-19COVID-19 vaccineHypertonieRisikofaktorenantihypertensive Therapieantihypertensive therapyblockers of the renin-angiotensin systemfacteurs de risquehypertensionhypertension artérielleloqueurs du système rénine-angiotensinerisk factorstraitement antihypertenseurvaccination Covid-19

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

961
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.2K

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
331
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
284
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
160
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
191
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
331